The healthcare sector is inundated with numerous AI products, prompting Duke Health in Durham, N.C., to establish an AI testing lab dedicated to heart care. This lab's primary goal is to assess the effectiveness of these AI tools in real-world clinical settings, ensuring they are beneficial for their intended purposes and contribute to improved patient outcomes.
Dr. Manesh Patel, chief of the division of cardiology and clinical pharmacology at Duke, highlighted the lab's mission to Becker’s. He emphasized that the lab would apply rigorous testing methods, similar to those used in drug and device evaluations, to determine the utility of AI tools. These tools range from those promoting medication adherence and exercise to advanced AI capable of predicting lethal heart rhythms.
The lab, located within Duke's heart center, represents a collaborative effort between clinicians and data scientists. This partnership aims to leverage the resources of large health systems to automate and enhance frontline care. Dr. Patel expressed the ambition to incorporate these AI tools effectively into clinical practice, improving care delivery and patient outcomes.
Currently, three projects are in progress at the lab, though specific details remain confidential to maintain the studies' integrity. This initiative reflects Duke Health's commitment to integrating innovative technologies into healthcare to better serve patients.
Click here to read the original news story.